t
Norman Broadbent Plc announced that on 13 June 2025, its Chief Executive Officer, Kevin Davidson, purchased 2,696 ordinary shares at an average price of 147.4 pence per share. Following this transaction, Kevin Davidson holds a beneficial interest in 19,238 Ordinary Shares, representing approximately 1.01% of the Company's issued share capital.
| Date | 16 Jun 2025 |
| Time | 07:00:12 |
| Category | Director/PDMR dealings |
| ID | 8743M |
16 June 2025
Norman Broadbent Plc
("Norman Broadbent", the "Company" or the "Group")
Director/PDMR Dealing
Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, announces that it has been notified that, on 13 June 2025, Kevin Davidson, Chief Executive Officer, purchased 2,696 ordinary shares at an average price of 147.4 pence per share.
Following this purchase, Kevin Davidson has a beneficial interest in 19,238 Ordinary Shares, representing approximately 1.01 per cent. of the Company's issued share capital.
Contacts:
|
Norman Broadbent plc |
+44 (0)20 7484 0000 |
|
Kevin Davidson, CEO |
|
|
Mehr Malik, CFO
|
|
|
|
|
|
Shore Capital (Nominated Adviser and Broker) |
+44 (0)20 7408 4090 |
|
Tom Griffiths / Tom Knibbs (Corporate Advisory) |
|
|
Henry Willcocks (Corporate Broking)
|
|
|
|
|
|
Alma (Financial Communications Adviser) |
+44 (0)20 3405 0205 |
|
Rebecca Sanders-Hewett |
|
|
Kinvara Verdon |
|
|
David Ison |
|
About Norman Broadbent:
Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.
Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.